glp 1 agonist therapy Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety Metabolic Flux Adaptations During GLP-1
Description
Numerous other trials have demonstrated positive cardiovascular outcomes with focus on HFpEF in the SUMMIT trial for tirzepatide and the STEP-HFpEF trial for semaglutide [50,51,52]
J Clin Endocrinol Metab 2019;104:2463-72.ArticlePubMed 43
Due to their diverse structures, the pharmacokinetic profiles vary, and a prolonged half-life may be associated with an increased risk of adverse events
IGB, Intragastric balloon
Front Behav Neurosci (2021) 15:724030
Ask your healthcare provider if you fall into one of these groups
